Mike Pompeo thanks Mahindra Group for making 'life-saving equipment' in the US

Chairman of Mahindra Group, Anand Mahindra, had earlier tweeted about the aerosol box designed by MAgNA which protects health workers while they're intubating patients.

CNBC-TV18

April 20, 2020 / 11:16 PM IST

Anand Mahindra

US Secretary of State Mike Pompeo has thanked the Mahindra Group, for manufacturing "life-saving equipment" in Detroit, Michigan.

Mahindra's American unit, Mahindra Ag North America, or MAgNA, recently started manufacturing collapsible aerosol boxes at its facility in Auburn Hills, Detroit. The company's facility was already manufacturing other protective medical equipment such as face masks and shields.

Michigan-based news portal The Detroit News said that Mahindra Group was joining the "arsenal of health" efforts spearheaded by Ford and GM, which was promptly acknowledged by Secretary Pompeo in tweet that read: "Thank you to the Mahindra Group for rising to the occasion and using your facilities to manufacture life-saving equipment."

Thank you to the Mahindra Group for rising to the occasion and using your facilities to manufacture life-saving equipment. https://t.co/890KEcF1R8

— Secretary Pompeo (@SecPompeo) April 20, 2020

Chairman of Mahindra Group, Anand Mahindra, had earlier tweeted about the aerosol box designed by MAgNA which protects health workers while they're intubating patients.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show